𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic–pharmacodynamic model for the anticholinergic effect of glycopyrrolate

✍ Scribed by Jani Penttilä; Antti Helminen; Kirsti Luomala; Harry Scheinin


Publisher
Springer
Year
2001
Tongue
English
Weight
133 KB
Volume
57
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Modeling the pharmacokinetics and pharma
✍ A. W. Kelman; P. A. Meredith; H. L. Elliott; J. L. Reid 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

The pharmacokinetics and pharmacodynamics of trimazosin are described following both intravenous and oral administration to 6 normotensive, male volunteers. The IV and oral drug and metabolite (l-hydroxytrimazosin) concentration data are fitted simultaneously to the same pharmacokinetic model. The p

Pharmacokinetic–pharmacodynamic modeling
✍ Takayuki Katsube; Yoshinori Yamano; Yoshitaka Yano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to simulate in vivo bactericidal effects for three carbapenem antibiotics, doripenem (DRPM), meropenem (MEPM)/cilastatin (CS), and imipenem (IPM)/CS, against a Pseudomonas aeruginosa (P. aeruginosa) strain is proposed. The PD model we hav

Pharmacokinetic–pharmacodynamic modeling
✍ Takayuki Katsube; Yoshitaka Yano; Yoshinori Yamano; Tadashi Munekage; Naomi Kuro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to explain the data from an in vitro dynamic model is proposed. Two carbapenem antibiotics, doripenem and meropenem, and three Pseudomonas aeruginosa strains were used as example drugs and strains. The PD model we originally developed to